Inhibitors of adenosine deaminase and the development of antiviral agents.
S S
SS
Cohen
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D003561:Cytarabine / Q000494:pharmacology; D003839:Deoxyadenosines / Q000494:pharmacology; D004357:Drug Synergism; D006561:Herpes Simplex / Q000188:drug therapy; D006801:Humans; D007372:Interferons / Q000096:biosynthesis; D051379:Mice; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D012435:S-Adenosylhomocysteine / Q000378:metabolism; D012436:S-Adenosylmethionine / Q000494:pharmacology
D058892:Adenosine Deaminase Inhibitors; D000998:Antiviral Agents; D003839:Deoxyadenosines; D003561:Cytarabine; C010192:9-(2-hydroxy-3-nonyl)adenine; D012436:S-Adenosylmethionine; D007372:Interferons; D012435:S-Adenosylhomocysteine; D009700:Nucleoside Deaminases; D000225:Adenine